Antonin Lallement

发表

Treatment of HCC with Claudin-1 specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironment.

N. Bardeesy, Y. Hoshida, C. Schuster, 2022, Journal of Hepatology.

A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity

T. Roskams, Y. Hoshida, C. Schuster, 2022, Science Translational Medicine.